Catalyst Pharmaceutical
CPRX
CPRX
86 hedge funds and large institutions have $94.3M invested in Catalyst Pharmaceutical in 2018 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 22 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
51% less capital invested
Capital invested by funds: $193M → $94.3M (-$98.6M)
72% less call options, than puts
Call options by funds: $32K | Put options by funds: $113K
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
86
Holding in Top 10
–
Calls
$32K
Puts
$113K
Top Buyers
| 1 | +$6.45M | |
| 2 | +$2.89M | |
| 3 | +$2.17M | |
| 4 |
BlackRock
New York
|
+$1.38M |
| 5 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$1.33M |
Top Sellers
| 1 | -$17M | |
| 2 | -$5.86M | |
| 3 | -$4.17M | |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$3.94M |
| 5 |
JC
JBF Capital
Aspen,
Colorado
|
-$1.92M |